Turning Cancer Cells into Muscle Cells: CRISPR Technology Takes the Stage

Every successful drug has a story of discovery, and this kind of research provides fertile ground for new medicines. Rhabdomyosarcoma (RMS) is a devastating, aggressive childhood cancer whose cells resemble children's muscle cells. Professor Christopher Vakoc and his team at Cold Spring Harbor Laboratory are studying a way to turn these cancer cells into muscle cells, potentially marking the beginning of a scientific breakthrough that could transform cancer treatment.

Once a Cancer Cell, Now Muscle

The team led by Christopher Vakoc and Martyna Sroka discovered a method that can turn RMS cells into muscle cells. During this transformation, the cells acquire typical muscle characteristics and functions. This happens when a protein called NF-Y is depleted from the cells. Without NF-Y, the cancer stops proliferating and begins to take on typical muscle characteristics.

A New Treatment Approach: Differentiation Therapy

This treatment approach is known as differentiation therapy . It was previously unclear whether it could work in RMS, but research in Vakoc's laboratory has now made it a real possibility. The team developed a new genetic screening technique using CRISPR to identify genes that could turn RMS cells into muscle cells. In the process, they discovered that NF-Y plays a critical role in this transformation.

CRISPR-Based Genetic Targeting: A Revolutionary Approach to Cancer Treatment

In recent years, CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology has revolutionized gene editing . This technology allows scientists to target and modify specific genes in DNA, opening new doors for treating diseases. In this latest rhabdomyosarcoma research, CRISPR-based genetic targeting revealed that the absence of NF-Y could enable cancer cells to turn into normal muscle cells.

The CRISPR Technique Used in the Study

1. Gene Identification: First, researchers use genetic screening methods to identify genes that might enable RMS cells to become normal muscle cells. In this study, NF-Y was identified as playing a critical role.
2. Gene Editing: The CRISPR-Cas9 system allows a specific gene, in this case the NF-Y gene complex, to be targeted and edited. It uses RNA molecules to recognize the target gene and cuts the DNA using an enzyme called Cas9.
3. Gene Inactivation: The Cas9 enzyme cuts the NF-Y gene, causing it to lose its function and triggering cellular differentiation.

The illustration above shows RMS cells turning into healthy muscle cells. When NF-Y is depleted from the cells, the cancer stops proliferating and starts acquiring typical muscle characteristics and functions. The microscopy images in the bottom row show actual cells before and after this transformation.

Application

In this study, CRISPR technology was used to target and inactivate the NF-Y gene complex. This inactivation causes loss of function of the PAX3-FOXO1 fusion protein, which prevents myogenic differentiation, or transformation into muscle cells, in RMS. As a result, the cells begin to turn into normal muscle cells, stopping the uncontrolled proliferation of cancer cells and restoring normal cellular functions.

The Newly Discovered Relationship Between NF-Y and RMS

This discovery could set off a chain reaction that brings differentiation therapy to patients. The technology may also apply to other cancers, meaning scientists could one day learn to turn other tumors into healthy cells.

Treatment of the Future: More Accessible Differentiation Therapy

Vakoc emphasizes that this technology could potentially be used to study any cancer and determine how to make it differentiate. This could be a critical step toward making differentiation therapy more accessible.

Support and Hope: Families and Vakoc's Laboratory

Cancer discoveries at Cold Spring Harbor Laboratory are supported by local families who have lost loved ones to these cancers. Vakoc says, "With some desperation, they came together to try to find a new treatment strategy, and they funded us". Now, these families and Vakoc's laboratory may become the driving forces behind a scientific breakthrough that could save children's lives and fundamentally change cancer treatment.